NEW MJ NEWS

AbbVie to Host Fourth-Quarter 2022 Earnings Conference Call

AbbVie (NYSE: ABBV) will announce its fourth-quarter 2022 financial results on Thursday, February 9, 2023, before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. CT. It will be accessible through AbbVie’s Investor Relations website investors.abbvie.com. An archived edition of the session will be available later that day.

About AbbVie

AbbVie’s mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn.

View original content to download multimedia:https://www.prnewswire.com/news-releases/abbvie-to-host-fourth-quarter-2022-earnings-conference-call-301711231.html

SOURCE AbbVie


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

$CANV to Attend Upcoming Investment Conferences

CannaVest Corp. to Attend Upcoming Investment Conferences CannaVest Corp. (CANV) (the “Company,”…

GTEC Holdings Ltd. (GGTTF) Signs Agreement to Become Exclusive Cannabis Supplier

GTEC Signs Agreement to Become Exclusive Cannabis Supplier Within National Pharmacy Distribution…

$MSRT to Release Revamped Website

MassRoots to Release Revamped Website in Anticipation of Annual 4/20 Traffic Surge…

Namaste Technologies Inc. (NXTTF) Announces February 2018 Sales of C$1.37M Representing a 146% Year-Over-Year Increase

Namaste Announces February 2018 Sales of C$1.37M Representing a 146% Year-Over-Year Increase…